Company: PTHS
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001753926-25-000503
Chunk: 163

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 1
Chunk 163
---
     —  
     20,000  
     —  
     210,115 

    Chia-Lin Simmons 
     14,396  
        
     183,675  
     —  
     20,000  
     —  
     218,071 

(1)
Amounts reflect the aggregate grant date fair value of the stock options granted to each named executive officer during the fiscal
year ended December 31, 2024 and 2023, as computed in accordance with Financial Accounting Standards Board ASC 718.

95 

Policies
and Practices Related to The Grant of Certain Equity Awards

We
maintain the 2023 Plan through which we grant equity awards, including stock options and stock appreciation rights, to our named
executive officers, other employees, and directors as part of our compensation program. In addition, certain employment agreements
with our named executive officers provide for the grant of such equity awards. We do not currently have a formal policy governing
the timing of grants of stock options, stock appreciation rights, or similar option-like instruments to named executive officers
or directors in relation to the release of material nonpublic information. Equity awards under the 2023 Plan have been granted
from time to time, including to directors to encourage their initial or continued service on our board of directors. Our board
of directors is evaluating the adoption of a policy concerning the timing of such awards relative to material non-public information
disclosures. We have not adopted any practice of timing, and do not time, the release of material non-public information to affect
the value of equity awards granted to named executive officers or directors.

During the year
ended December 31, 2024, there were no equity grants made to our executive officers during any period beginning four business days
before the filing of a periodic report or current report disclosing material non-public information and ending one business day
after the filing or furnishing of such report with the SEC. 

Item
12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 

The
following table sets forth certain information regarding the beneficial ownership of our capital stock as of March 21, 2025 by
(a) each person, or group of affiliated persons, who is known to us to own beneficially 5% or more of our outstanding equity securities;
(b) each of our directors; (c) each of our named executive officers